Assets
Biography
2020: Purchase of 80% of QuantBioRes shares
In mid-January 2022, Serbian tennis player Novak Djokovic acquired an 80% stake in the biotechnology company QuantBioRes, which develops a drug for coronavirus (COVID-19) infection. The developer expects to begin clinical trials in the UK in the summer of 2022. It is reported by Reuters with reference to the executive director of the company Ivan Lonkarevich. More details here.
| The site content is translated by machine translation software powered by PROMT. The machine-translated articles are not always perfect and may contain errors in vocabulary, syntax or grammar. Read original article If you find inaccuracies or errors in the results of machine translation, please write to editor@tadviser.ru. We will make every effort to correct them as soon as possible. |